VSL#3: An Analysis of Basic and Clinical Contributions in Probiotic Therapeutics
- 30 September 2005
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 34 (3) , 499-513
- https://doi.org/10.1016/j.gtc.2005.05.003
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- VSL3 probiotic mixture induces remission in patients with active ulcerative colitisGastroenterology, 2003
- Anatomical basis of tolerance and immunity to intestinal antigensNature Reviews Immunology, 2003
- Probiotics: Isolated bacteria strain or mixtures of different strains?Drugs of Today, 2003
- Defensins – innate immunity at the epithelial frontierEuropean Journal of Gastroenterology & Hepatology, 2001
- Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6Journal of Clinical Investigation, 2001
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.Gut, 1994
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991
- Probiotics: Growth-Promoting Factors Produced by MicroorganismsScience, 1965